Efficacy and Safety in a Randomised Acute Pain Study of MR308: STARDOM2.
Status:
Completed
Trial end date:
2018-06-29
Target enrollment:
Participant gender:
Summary
The MR308-3502 study is a multicenter double-blind, randomised, placebo- and active
comparator-controlled study in female subjects to evaluate the efficacy and safety of MR308
with acute pain after TAH or STAH (total or subtotal abdominal hysterectomy).